Ear stimulation trial aims to ease chemotherapy digestive distress in ovarian cancer

NCT ID NCT06817161

Summary

This study is testing whether a gentle electrical stimulation device placed on the ear can improve quality of life for women undergoing first-line chemotherapy for ovarian cancer. It specifically aims to reduce digestive symptoms like nausea and discomfort that often accompany treatment. Participants will be randomly assigned to receive either the real stimulation or a placebo version using the same device.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU CAEN

    NOT_YET_RECRUITING

    Caen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre François Baclesse

    RECRUITING

    Caen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Henri Becquerel

    NOT_YET_RECRUITING

    Rouen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Oscar Lambret

    NOT_YET_RECRUITING

    Lille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.